Effect of bisphosphonates on orthodontic tooth movement in osteoporotic patients with maxillofacial radiological point: A systematic review

Osteonecrosis is a lateral complication in patients receiving base phosphonates. This complication rarely occurs; if it does, it can cause serious problems for patients and can even lead to pathological fractures in the mandibular. It is aimed to evaluate the effect of bisphosphonates on orthodontic tooth movement in osteoporotic patients with maxillofacial radiological point. For this, 64 articles published between January 2004 and November 2024 in the Scopus Wiley Online Library, Web of Science, Cochrane Central Register of Controlled Trials, EBSCO, ISI, Elsevier, and the Google Scholar search engine were reviewed using relevant keywords ("Orthodontics," "Base Phosphonates," "Osteoporotic patients"). Osteoporosis can create unique challenges for dental treatments. There are unlikely to exist medications that stimulate dental movements. Nonetheless, while some efforts are currently being made to develop a few medicines, their application has not yet accelerated orthodontic treatment. However, some medications slow toothpaste in the treatment of orthodontics that may be unintentionally used by the patient. These drugs are the processes of glandin, such as NSAIDS (analgesic drugs: ibuprofen, aspirin, and naproxen), which can lead to a decrease in tooth movement and subsequently prolong the duration of orthodontic treatment. Therefore, people in the process of orthodontic treatment should avoid continuous use of these non-steroidal anti-inflammatory drugs, or so-called NSAIDS. Individuals undergoing orthodontic treatment ought to substitute these painkillers with acetaminophen in order to prevent dental movements from impairing them.